2020 Targeting ALK - From Discovery to Frontline Treatment
6 意见
• 07/30/23
0
0
嵌入
In this 'keynote', Dr. Yael Mosse presents on the discovery of ALK aberrations in neuroblastoma, their significance at diagnosis and at relapse, drug development strategies and plans to incorporate ALK inhibitors into frontline therapy with potential joint COG and SIOPEN studies, and germline ALK mutation.
显示更多
脸书评论
SORT BY-
热门评论
-
最新评论